Cassava Sciences- Warrants (15/11/2024) Profit Margin

Cassava Sciences- Warrants (15/11/2024)'s profit margin stands at -5033.33% as of June 2026. That is below the Healthcare sector average of 13.89%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Cassava Sciences- Warrants (15/11/2024) sits lower the Healthcare benchmark (13.89%) with a profit margin of -5033.33%. That is roughly 36329.1% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -5033.33% for Cassava Sciences- Warrants (15/11/2024) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Cassava Sciences- Warrants (15/11/2024)'s profit margin evolved across reporting periods, while the comparison chart places SAVAW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, profit margin is commonly used to spot outliers. Cassava Sciences- Warrants (15/11/2024)'s reading of -5033.33% (sector avg 13.89%) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.